Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind

Autoimmunity Reviews
Ricardo SilvariñoRicard Cervera

Abstract

Systemic autoimmune diseases are conditions of unknown etiology, characterized by the simultaneous or successive involvement of most organs and systems, as well as the presence of autoantibodies as biological markers. Venous thromboembolic disease has a higher incidence in this population when compared to healthy individuals. This responds to the increase in congenital and acquired risk factors in this group. One of the main risk factors is linked to the presence of antiphospholipid antibodies, whose prevalence is increased among patients with such conditions.

References

Jan 24, 1994·Archives of Internal Medicine·A CogoA Girolami
Sep 1, 1997·Clinical Immunology and Immunopathology·D L JacobsonN M Graham
Mar 22, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·N RegéczyG Szegedi
Apr 16, 2002·Arthritis and Rheumatism·Ricard CerveraUNKNOWN Euro-Phospholipid Project Group
Nov 15, 2002·Thrombosis Research·Elisabeth AltRenate Koppensteiner
Nov 26, 2002·Clinical Rheumatology·T M K RefaiM H Al-Salem
Jun 10, 2003·Clinical Reviews in Allergy & Immunology·Ronald A Asherson, Ricard Cervera
Jun 4, 2005·Arthritis and Rheumatism·Antonella AfeltraAntonio Amoroso
Feb 8, 2006·Arthritis and Rheumatism·Sven WeidnerHarald D Rupprecht
May 29, 2007·Arthritis and Rheumatism·Stephanie BoothTammy O Utset
Dec 1, 2007·Arthritis and Rheumatism·Guillermo Ruiz-IrastorzaMunther A Khamashta
Jan 15, 2008·Autoimmunity Reviews·Ricard Cervera
Feb 5, 2008·Annals of the Rheumatic Diseases·G HatemiUNKNOWN EULAR Expert Committee
Dec 23, 2008·Thrombosis Research·Vanessa RoldanUNKNOWN RIETE Investigators
Dec 24, 2008·Annals of the Rheumatic Diseases·G Ruiz-IrastorzaM A Khamashta
Apr 24, 2009·Autoimmunity Reviews·A TincaniR Cattaneo
Sep 19, 2009·Lupus·V BellomioUNKNOWN SLE Study Group of the Argentinean Society of Rheumatology
Apr 3, 2010·The Open Cardiovascular Medicine Journal·Micaela La ReginaDomenico Prisco
Dec 25, 2010·Srpski arhiv za celokupno lekarstvo·Dragan M Pavlović, Aleksandra M Pavlović
May 7, 2011·Autoimmunity Reviews·Cristiano AlessandriGuido Valesini
May 12, 2011·Autoimmunity Reviews·Tina ScobleMunther A Khamashta
May 17, 2011·Autoimmunity Reviews·Gerard EspinosaRicard Cervera

❮ Previous
Next ❯

Citations

Apr 22, 2014·Rheumatology International·Patompong Ungprasert, Anawin Sanguankeo
Apr 8, 2015·Modern Rheumatology·Patompong UngprasertWonngarm Kittanamongkolchai
Nov 12, 2015·Autoimmunity Reviews·Delphine TurpinPierre Duffau
Jul 15, 2015·Autoimmunity Reviews·M Lecouffe-DespretsM Hamidou
Apr 10, 2014·QJM : Monthly Journal of the Association of Physicians·Patompong UngprasertPromporn Suksaranjit
Nov 29, 2016·Lung India : Official Organ of Indian Chest Society·Patompong UngprasertWonngarm Kittanamongkolchai
Jan 29, 2021·Frontiers in Medicine·Naureen Narula, Michael Iannuzzi
Mar 25, 2021·The American Journal of Cardiology·Nikhil KolluriJohn P Bois
Jul 3, 2021·Journal of Clinical Medicine·Barbara RuaroFrancesco Salton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.